Page last updated: 2024-08-16

temozolomide and iguratimod

temozolomide has been researched along with iguratimod in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Faming, W; Hang, S; Hongyan, Z; Liudi, Y; Mengmeng, T; Younis, M	1

Other Studies

1 other study(ies) available for temozolomide and iguratimod

Article	Year
Iguratimod encapsulated PLGA-NPs improves therapeutic outcome in glioma, glioma stem-like cells and temozolomide resistant glioma cells. Nanomedicine : nanotechnology, biology, and medicine, 2019, Volume: 22 Topics: Animals; Apoptosis; Blood-Brain Barrier; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Self Renewal; Chromones; Drug Resistance, Neoplasm; Glioma; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplastic Stem Cells; Polylactic Acid-Polyglycolic Acid Copolymer; Spheroids, Cellular; Sulfonamides; Temozolomide; Treatment Outcome	2019

Article

Year

Iguratimod encapsulated PLGA-NPs improves therapeutic outcome in glioma, glioma stem-like cells and temozolomide resistant glioma cells.

Nanomedicine : nanotechnology, biology, and medicine, 2019, Volume: 22

Topics: Animals; Apoptosis; Blood-Brain Barrier; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Self Renewal; Chromones; Drug Resistance, Neoplasm; Glioma; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplastic Stem Cells; Polylactic Acid-Polyglycolic Acid Copolymer; Spheroids, Cellular; Sulfonamides; Temozolomide; Treatment Outcome

2019